Using a multi-strain infectious disease model with physical information neural networks to study the time dependence of SARS-CoV-2 variants of concern.

Publication date: Feb 01, 2025

With the ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its increasing adaptation to humans, several variants of concern (VOCs) and variants of interest (VOIs) have been identified since late 2020. These include Alpha, Beta, Gamma, Delta, Omicron parent lineage, and other variants. These variants may show distinct levels of virulence, antigenicity, and infectivity, which require specific defense and control measures. In this study, we propose an [Formula: see text] infectious disease model to simulate the spread of SARS-CoV-2 variants among the human population. We combine the proposed epidemic model and reported infected data of variants with physical information neural networks (PINNs) to develop a novel mechanism called VOCs-informed neural network (VOCs-INN). In our experiments, we found that this algorithm can accurately fit the reported data of the British Columbia (BC) province and its five internal health agencies in Canada. Furthermore, it can simulate observed or unobserved dynamics, infer time-dependent parameters, and enable short-term predictions. The experimental results also reveal variations in the intensity of control strategies implemented across these regions. VOCs-INN performs well in fitting and forecasting when analyzing long-term or multi-wave data.

Open Access PDF

Concepts Keywords
Antigenicity Algorithms
Canada British Columbia
Coronavirus Computational Biology
Fit Computer Simulation
Parent COVID-19
Epidemiological Models
Humans
Neural Networks, Computer
SARS-CoV-2

Semantics

Type Source Name
disease MESH infectious disease
pathway REACTOME Infectious disease
disease IDO virulence
disease IDO infectivity
disease IDO algorithm
disease IDO history
disease IDO process
pathway REACTOME Reproduction
disease MESH COVID 19
drug DRUGBANK Coenzyme M
disease IDO intervention
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH aids
disease MESH infections
disease IDO infection
disease MESH secondary infections
disease IDO susceptible population
disease IDO host
drug DRUGBANK Methionine
disease MESH uncertainty
drug DRUGBANK Isoxaflutole
drug DRUGBANK Guanosine
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease IDO pathogen
drug DRUGBANK Carboxyamidotriazole
disease MESH emergency
pathway KEGG Coronavirus disease

Original Article

(Visited 1 times, 1 visits today)